February 18, 2010 — MedImmune, a biopharmaceutical companyin Gaithersburg and the biologics business for AstraZeneca, has appointed Peter Greenleaf as its new president. Beforehad, Greenleaf served as MedImmune's senior vice president, marketing and sales. Prior to that, he was franchise vice president at Centocor and also worked for Boehringer Mannheim Corp. and US Healthcare.
 |
 |
 |
|
||
 |
|
 |
|
||
| Corridor Inc.’s New Strategic Partners |
 Click here to visit CenterMaryland.org |
 Click here to visit PressBoxonline.com |
 Click here to visit GBC.org |
READ Corridor's Current
Digital Edition:
2011 Person of the Year
Nominees
|
|
| CLICK HERE FOR MARYLAND'S DEPARTMENT OF BUSINESS AND ECONOMIC DEVELOPMENT NEWSLETTER |
